Carriers of X-linked chronic granulomatous disease at risk.
Roesler
Joachim
J
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005091:Exons / Q000235:genetics; D005260:Female; D050172:Genes, X-Linked / Q000235:genetics; D005817:Genetic Counseling; D006105:Granulomatous Disease, Chronic / Q000150:complications / Q000175:diagnosis* / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D012306:Risk; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D017964:Itraconazole; D015662:Trimethoprim, Sulfamethoxazole Drug Combination